Last Price$4.72NASDAQ Closing Price as of 4:00PM ET 8/12/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.25(5.03%)
Bid (Size)$4.66 (1)
Ask (Size)$4.68 (54)
Day Low / High$4.47 - 5.05
Volume21.1 M

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/12/2020


OPKO Health Inc ( NASDAQ )

Price: $4.72
Change: -0.25 (5.03%)
Volume: 21.1 M
4:00PM ET 8/12/2020

Reata Pharmaceuticals Inc ( NASDAQ )

Price: $103.20
Change: -0.40 (0.39%)
Volume: 651.6 K
3:59PM ET 8/12/2020

Biohaven Pharmaceutical Holding Company Ltd ( NYSE )

Price: $59.40
Change: -0.39 (0.65%)
Volume: 517.5 K
4:10PM ET 8/12/2020

Nektar Therapeutics ( NASDAQ )

Price: $20.10
Change: -0.30 (1.47%)
Volume: 670.7 K
3:59PM ET 8/12/2020

Principia Biopharma Inc ( NASDAQ )

Price: $87.34
Change: +3.18 (3.78%)
Volume: 246.1 K
3:59PM ET 8/12/2020

Read more news Recent News

Sector Update: Health Care Stocks Rising in Wednesday Trading
4:00PM ET 8/12/2020 MT Newswires

Health care stocks extended their Wednesday advance, with the NYSE Health Care Index this afternoon rising 2.1% while the SPDR Health Care Select Sector...

Sector Update: Health Care Stocks Advancing This Afternoon
1:56PM ET 8/12/2020 MT Newswires

Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index rising 2% while the SPDR Health Care Select Sector ETF also was up...

Opko Unit Enters Deal With Pediatrix to Offer Neonatal Genomic Testing Services; Shares Tumble 8%
11:11AM ET 8/12/2020 MT Newswires

Opko Health Inc (OPK), a biopharmaceutical and diagnostics company, said Wednesday that its GeneDX subsidiary has entered into an agreement with Pediatrix...

2020 Estimate for OPKO Health Raised but 2021 Earnings Number Reduced
6:15AM ET 8/12/2020 MT Newswires

The 2020 and 2021 full year forecasted earnings estimates for OPKO Health Inc's (NASDAQ:OPK, Recent Price: 4.97) have been changed. The consensus estimate...

View all Commentary and Analysis

Wall Street Breakfast: Big Beats From Big Tech
7:04AM ET 7/31/2020 Seeking Alpha

OPKO Health's (OPK) CEO Phillip Frost on Q2 2020 Results - Earnings Call Transcript
9:43PM ET 7/30/2020 Seeking Alpha

Biotech Bonanza - Second Half Outlook
8:24AM ET 7/28/2020 Seeking Alpha

Eyeing Up An Earnings Trade In OPKO Health
7:50PM ET 7/21/2020 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Number of Employees5,690
Recent SEC Filing07/31/202010-Q
Chairman & Chief Executive OfficerPhillip Frost
Chief Financial Officer & Senior Vice PresidentAdam E. Logal
Vice Chairman & Chief Technical OfficerJane H. Hsaio
Director & Executive Vice President-AdministrationSteven D. Rubin

Company Highlights

Price Open$5.00
Previous Close$4.97
52 Week Range$1.12 - 6.47
Market Capitalization$3.2 B
Shares Outstanding669.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/03/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.24
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-20.69%
Return on Equity-12.50%

Analyst Ratings as of 02/27/2020

Consensus RecommendationConsensus Icon
Powered by Factset